EXANE DERIVATIVES: ACWI position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on ACWI, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 35,530 ACWI shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

period ended2022-06-30
13F 35,530 shares
Change vs previous 13F not available
1.71% of the 13F portfolio, value $2,980,004.
13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
Filed 2022-07-12 (acceptance time not in the bulk data set), ingested 2026-10-07 18:35:03 UTC
Acceptance time not in the bulk data set (spec §4.2).